Tag: Blood Disorders
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
Elevated RDW and increase in RDW during hospitalization linked to increased mortality risk
No Proof Convalescent Plasma Effective Against COVID-19
NIH panel says data are insufficient to recommend either for or against the use of convalescent plasma
WHO: Plasma Therapy for COVID-19 Still Experimental
FDA 'emergency use authorization' does not mean plasma therapy has been proven safe and effective
FDA Approves Wider Use of Plasma as COVID-19 Treatment
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
More data are under review; the approval could still be issued in the near future
Convalescent Plasma Efficacious for Severe COVID-19
Significant reduction seen in mortality, specifically among patients transfused with plasma within 72 hours
Evidence Poor for Accuracy of Serological Tests for COVID-19
Evidence for diagnostic accuracy of serological tests characterized by high risks of bias, heterogeneity
FBI Warns of Scammers Selling Fake COVID-19 Antibody Tests
Consumers can protect themselves by checking FDA website for a list of approved antibody tests, testing companies
Antibody Tests ID COVID-19 Two to Three Weeks After Symptoms
After onset of symptoms, sensitivity is low in first week, increases in second week, peaks in third week
Convalescent Plasma Safe for Diverse Patients With COVID-19
Incidence of SAEs, including transfusion reactions, thromboembolic or thrombotic events, is low
